
Commentary|Podcasts|August 25, 2023
Pharmacy Focus: Dangers of Drug Diversion for Health Care Professionals
Tom Knight, founder and CEO of Invistics, now part of Wolters Kluwer, discusses the dangers of drug diversion and how this could negatively impact affect patients.
Advertisement
In this week's episode of Pharmacy Focus, Tom Knight, founder and CEO of Invistics, now part of Wolters Kluwer, discusses the dangers of drug diversion and how this could negatively impact affect patients and health care professionals.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial
2
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer?
3
Common Asthma Drug May Supercharge Cancer Immunotherapy, Study Finds
4
Navigating the New Era of Hemophilia Care: Insights From the Pharmacy Times Peer Exchange
5





































































































































